Bullish
Alto Neuroscience reports Q1 2026 net loss of $26.2M, cash of $264.2M after $120M PIPE
Alto Neuroscience reported a net loss of $26.2 million for Q1 2026, an increase from $15.2 million in Q1 2025, but ended the quarter with $264.2 milli...